C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia

作者: U. Thiem , D. Niklaus , B. Sehlhoff , C. Stuckle , H. J. Heppner

DOI: 10.1093/AGEING/AFP164

关键词:

摘要: Background: increasingly, markers of systemic inflammation like C-reactive protein (CRP) levels and white blood count (WBC) are being used for assessing the prognosis patients with community-acquired pneumonia (CAP). However, their predictive value has not been validated in populations elderly patients. Objective:toevaluatetheprognosticvalueofCRPandWBCincomparisonwiththeCURBscoreandthepneumoniaseverity index (PSI) elderly, hospitalised CAP. Methods:thechartsofallpatients,aged65yearsandolder,whowereconsecutivelyadmittedtotheDepartmentofGeriatrics, Marienhospital Herne, Germany, treatment CAP between January 2001 September 2005, were reviewed. CRP, WBC, CURB PSI analysed relation to 30-day mortality. Results: a total 391 patients, median age 80 years, no association was found CRP or WBC In contrast, score significantly associated mortality intensive care unit (ICU). Conclusion: CAP, admission predictors prognosis.

参考文章(29)
Tateaki Naito, Takafumi Suda, Kazumasa Yasuda, Takashi Yamada, Akihito Todate, Tomoyoshi Tsuchiya, Jun Sato, Kingo Chida, Hirotoshi Nakamura, A Validation and Potential Modification of the Pneumonia Severity Index in Elderly Patients with Community-Acquired Pneumonia Journal of the American Geriatrics Society. ,vol. 54, pp. 1212- 1219 ,(2006) , 10.1111/J.1532-5415.2006.00825.X
F.M. Brunkhorst, B. Al-Nawas, F. Krummenauer, Z.F. Forycki, P.M. Shah, Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia Clinical Microbiology and Infection. ,vol. 8, pp. 93- 100 ,(2002) , 10.1046/J.1469-0691.2002.00349.X
Beat Müller, Stephan Harbarth, Daiana Stolz, Roland Bingisser, Christian Mueller, Jörg Leuppi, Charly Nusbaumer, Michael Tamm, Mirjam Christ-Crain, Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia BMC Infectious Diseases. ,vol. 7, pp. 10- 10 ,(2007) , 10.1186/1471-2334-7-10
Jordi Almirall, Ignasi Bolibar, Pere Toran, Guillem Pera, Xavier Boquet, Xavier Balanzó, Goretti Sauca, Community-Acquired Pneumonia Maresme Study Group, None, Contribution of C-Reactive Protein to the Diagnosis and Assessment of Severity of Community-Acquired Pneumonia Chest. ,vol. 125, pp. 1335- 1342 ,(2004) , 10.1378/CHEST.125.4.1335
Steven Black, Irving Kushner, David Samols, C-reactive Protein Journal of Biological Chemistry. ,vol. 279, pp. 48487- 48490 ,(2004) , 10.1074/JBC.R400025200
Robin P. Smith, Brian J. Lipworth, Ian A. Cree, Elizabeth M. Spiers, John H. Winter, C-Reactive Protein: A Clinical Marker in Community-Acquired Pneumonia Chest. ,vol. 108, pp. 1288- 1291 ,(1995) , 10.1378/CHEST.108.5.1288
Robin P. Smith, Brian J. Lipworth, C-Reactive Protein in Simple Community-Acquired Pneumonia Chest. ,vol. 107, pp. 1028- 1031 ,(1995) , 10.1378/CHEST.107.4.1028